Patents by Inventor Bjarne Bymose

Bjarne Bymose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of hyperproliferative conditions of body surfaces
    Patent number: 8263567
    Abstract: The present invention relates to pharmaceutical formulations comprising an anthracycline and the uses thereof for treatment of clinical conditions of body surfaces such as skin and mucosal membranes, wherein abnormal cell differentiation and/or hyperproliferation is a primary factor of the pathogenesis. In particular the invention relates to treatment of psoriasis, and preferably to treatment of psoriasis with valrubicin topically applied.
    Type: Grant
    Filed: January 28, 2008
    Date of Patent: September 11, 2012
    Assignee: Valderm APS
    Inventors: Bjarne Bymose, Thomas Broe Christensen
  • TREATMENT OF HYPERPROLIFERATIVE CONDITIONS OF BODY SURFACES
    Publication number: 20080119546
    Abstract: The present invention relates to pharmaceutical formulations comprising an anthracycline and the uses thereof for treatment of clinical conditions of body surfaces such as skin and mucosal membranes, wherein abnormal cell differentiation and/or hyperproliferation is a primary factor of the pathogenesis. In particular the invention relates to treatment of psoriasis, and preferably to treatment of psoriasis with valrubicin topically applied.
    Type: Application
    Filed: January 28, 2008
    Publication date: May 22, 2008
    Inventors: Bjarne Bymose, Thomas Broe Christensen
  • Treatment of hyperproliferative conditions of body surfaces
    Patent number: 7345023
    Abstract: The present invention relates to pharmaceutical formulations comprising an anthracycline and the uses thereof for treatment of clinical conditions of body surfaces such as skin and mucosal membranes, wherein abnormal cell differentiation and/or hyperproliferation is a primary factor of the pathogenesis. In particular the invention relates to treatment of psoriasis, and preferably to treatment of psoriasis with valrubicin topically applied.
    Type: Grant
    Filed: August 12, 2002
    Date of Patent: March 18, 2008
    Assignee: Valderm ApS
    Inventors: Bjarne Bymose, Thomas Broe Christensen
  • Treatment of hyperproliferative conditions of body surfaces
    Publication number: 20040242507
    Abstract: The present invention relates to pharmaceutical formulations comprising an anthracycline and the uses thereof for treatment of clinical conditions of body surfaces such as skin and mucosal membranes, wherein abnormal cell differentiation and/or hyperproliferation is a primary factor of the pathogenesis. In particular the invention relates to treatment of psoriasis, and preferably to treatment of psoriasis with valrubicin topically applied.
    Type: Application
    Filed: July 23, 2004
    Publication date: December 2, 2004
    Inventors: Bjarne Bymose, Thomas Broe Christensen